Year: 2019
Type: editorial
Abstract: Chronic kidney disease (CKD) is one of the fastest growing causes of death worldwide. Only early diagnosis will allow prevention of both CKD progression and the negative impact of CKD on all-cause and cardiovascular mortality. Klotho is a protein produced by the kidneys that has anti-ageing and phosphaturic properties, preventing excess positive phosphate balance. There is evidence that Klotho downregulation is one of the earliest consequences of kidney injury. Thus the development of reliable assays to monitor Klotho levels may allow an early diagnosis of CKD and monitoring the impact of therapies aimed at preserving Klotho expression or at preventing CKD progression. However, the performance of Klotho assays has been suboptimal so far. In this issue of Clinical Kidney Journal, Neyra et al. explore methods to improve the reliability of Klotho assays.
Source: Clinical Kidney Journal
DOI: 10.1093/ckj/sfz125
Institutions: Fundación Renal Española, Universidad Autónoma de Madrid
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,335
Awards: Caracterización de nuevos factores nefroprotectores y aplicaciones terapéuticas, G1075404386, Nuevos abordajes para monitorizar y prevenir la necroinflamación en el daño renal agudo., Tratamiento personalizado de la Nefropatía por IgA, G1432989448, G1520406698, Reposicionamiento de nuevas formulaciones de 3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-diona para retrasar el envejecimiento por déficit de Klotho, G2170437373, G2312131674, G2605343809, G326643260, G3461049294, G3969019814, G4364775088, G5117888954, G6161449843, G6485122093, Inhibidores de NIK: Caracterización y aplicación en la enfermedad renal, Multidimensional stratification for treatment of acute kidney injury, G8323417318, Nuevas aproximaciones terapéuticas para la protección tisular en la enfermedad renal, G999562601
OpenAlex ID: W2975273448
